Helicos BioSciences Corp. (HLCS) Partners with Correlagen Diagnositcs Inc. to Provide Enhanced DNA-Assays

In the company’s news yesterday,

Helicos BioSciences Corp. announced the sale of a system and relative collaboration with Correlagen Diagnostics Inc., a leader in genetic testing for disease diagnosis. The company will purchase and use the Helicos Genetic Analysis System for testing based on resequencing broad panels of genes found to contribute to diseases in the areas of cardiology, endocrinology, neuropsychiatry and immunology, to name a few.

“We are very excited to have Correlagen as both a customer and collaborator, and look forward to working with them as they develop diagnostic tests on the Helicos® Genetic Analysis Platform” Ron Lowy, CEO of Helicos statd in the press release. “This relationship demonstrates our commercial progress in both the research market and in diagnostics.”

The Helicos Genetic Analysis System is the only commercially available single molecule sequencing technology. According to the company, the system allows for genetic analysis without DNA ligation or amplification. The system requires a small amount of material and sample preparation, thereby eliminating costs and errors associated with DNA amplification.

Helicos and Correlagen will work together to optimize sample preparation methodologies, data analysis and visualization technologies, as well as clinical reporting. David Margulies, president and CEO of Correlagen, said that utilizing Helicos’ system will enable the companies to generate unique assays.

“We believe that the Helicos System will allow us to provide DNA-based clinical assays of unprecedented value for the diagnosis of genetic disorders” Margulies stated. “Helicos was the obvious choice for the CLIA-certified genetic diagnostics arena given the unique characteristics of this single-molecule sequencing platform. Our assays will have unmatched breadth, precision, and clinical utility.”

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.